MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
MCB.00254-07v1
27/18/6383    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, Y.
Right arrow Articles by Benjamin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, Y.
Right arrow Articles by Benjamin, T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2007, p. 6383-6395, Vol. 27, No. 18
0270-7306/07/$08.00+0     doi:10.1128/MCB.00254-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

TAZ Promotes PC2 Degradation through a SCFß-Trcp E3 Ligase Complex{triangledown} ,{dagger}

Yu Tian,1 Robert Kolb,2 Jeong-Ho Hong,3,4 John Carroll,1 Dawei Li,1 John You,1 Roderick Bronson,1 Michael B. Yaffe,3 Jing Zhou,2 and Thomas Benjamin1*

Department of Pathology,1 Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115,2 Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139,3 School of Life Sciences and Biotechnology, Korea University, Anam-Dong, Seongbuk-Gu, Seoul 136-701, South Korea4

Received 12 February 2007/ Returned for modification 15 March 2007/ Accepted 22 June 2007

Studies of a TAZ knockout mouse reveal a novel function of the transcriptional regulator TAZ, that is, as a binding partner of the F-box protein ß-Trcp. TAZ–/– mice develop polycystic kidney disease (PKD) and emphysema. The calcium-permeable cation channel protein polycystin 2 (PC2) is overexpressed in kidneys of TAZ–/– mice as a result of decreased degradation via an SCFß-Trcp E3 ubiquitin ligase pathway. Replacements of serines in a phosphodegron motif in TAZ prevent ß-Trcp binding and PC2 degradation. Coexpression of a cytoplasmic fragment of polycystin 1 blocks the PC2-TAZ interaction and prevents TAZ-mediated degradation of PC2. Depletion of TAZ in zebrafish also results in a cystic kidney accompanied by overexpression of PC2. These results establish a common role of TAZ across vertebrate species in a protein degradation pathway regulated by phosphorylation and implicate deficiencies in this pathway in the development of PKD.


* Corresponding author. Mailing address: Department of Pathology, Harvard Medical School, Boston, MA 02115. Phone: (617) 432-1959. Fax: (617) 432-2689. E-mail: thomas_benjamin{at}hms.harvard.edu

{triangledown} Published ahead of print on 16 July 2007.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.


Molecular and Cellular Biology, September 2007, p. 6383-6395, Vol. 27, No. 18
0270-7306/07/$08.00+0     doi:10.1128/MCB.00254-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.